Neurosense Therapeutics Stock Statistic Functions Beta
| NRSN Stock | USD 0.95 0.02 2.15% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Neurosense Therapeutics correlated with the market. If Beta is less than 0 Neurosense Therapeutics generally moves in the opposite direction as compared to the market. If Neurosense Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Neurosense Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Neurosense Therapeutics is generally in the same direction as the market. If Beta > 1 Neurosense Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Neurosense Therapeutics Technical Analysis Modules
Most technical analysis of Neurosense Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurosense from various momentum indicators to cycle indicators. When you analyze Neurosense charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neurosense Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neurosense Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neurosense Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Neurosense Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neurosense Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Neurosense Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Neurosense Therapeutics, we also check how macroeconomic factors affect Neurosense Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 0.84 | 2.21 | 2.54 | 2.41 | Net Debt To EBITDA | 0.26 | 0.33 | 0.38 | 0.37 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neurosense Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neurosense Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neurosense Therapeutics' short interest history, or implied volatility extrapolated from Neurosense Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 100 shares | |
 | Blockchain Invested over 90 shares | |
 | Climate Change Invested over 30 shares | |
 | Macroaxis Picks Invested a lot of shares | |
 | Strategy ETFs Invested over 40 shares | |
| Size And Style ETFs Invested over 500 shares | |
| High Dividend Yield ETFs Invested few shares | |
 | Artificial Intelligence Invested over 500 shares | |
 | Giant Impact Invested few shares | |
 | Social Domain Invested over 100 shares | |
 | Adviser Favorites Invested over 300 shares | |
 | Macroaxis Index Invested over 60 shares | |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Biotechnology sector continue expanding? Could Neurosense diversify its offerings? Factors like these will boost the valuation of Neurosense Therapeutics. Anticipated expansion of Neurosense directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neurosense Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Neurosense Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Neurosense Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Neurosense Therapeutics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Neurosense Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neurosense Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Neurosense Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.